This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Fiore Cannabis Past Earnings Performance

Past criteria checks 0/6

Key information

3.1%

Earnings growth rate

40.5%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate35.0%
Return on equityn/a
Net Margin-414.2%
Last Earnings Update30 Jun 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Fiore Cannabis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:FIOR Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 222-1040
31 Mar 223-960
31 Dec 213-860
30 Sep 213-1250
30 Jun 213-1240
31 Mar 213-1760
31 Dec 202-4460
30 Sep 202-3870
30 Jun 202-40100
31 Mar 202-3890
31 Dec 193-27190
30 Sep 192-28210
30 Jun 192-26200
31 Mar 191-29210
31 Dec 181-27250
30 Sep 180-25220
30 Jun 180-24200
31 Mar 180-21170
31 Dec 171-1370
30 Sep 170-1360
30 Jun 170-1250
31 Mar 170-1040
31 Dec 160-620
30 Sep 160-410
30 Jun 160-310

Quality Earnings: FIOR is currently unprofitable.

Growing Profit Margin: FIOR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FIOR is unprofitable, but has reduced losses over the past 5 years at a rate of 3.1% per year.

Accelerating Growth: Unable to compare FIOR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FIOR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.8%).


Return on Equity

High ROE: FIOR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies